LENZ
LENZ
NASDAQ · Pharmaceuticals

Lenz Therapeutics Inc

$9.74
-1.26 (-11.45%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +43.5% upside
Low Target $9.74
Average Target $13.98
High Target $16.17
Current Price $9.74
Current
$9.74
Target
$13.98
$9.74 $13.98 avg $16.17
Scenario Analysis
Bear Case
$9.74
0.0%
Low target
Base Case
$13.98
+43.5%
Avg target
Bull Case
$16.17
+66.0%
High target
Price in Context
52-Week High
$50.40
-80.7% from high
52-Week Low
$11.83
+-17.7% from low
Target vs 52W High
$13.98
-72.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%